ReviewThe Biochemical journal2026
Protein S: a vitamin K-dependent factor bridging haemostasis, tissue homeostasis and cancer.
Review in The Biochemical journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Protein S (PROS1) is a vitamin K-dependent plasma glycoprotein that was originally described as a non-enzymatic cofactor of activated protein C in the regulation of blood coagulation. Over the past three decades, PROS1 has emerged as a pleiotropic signaling molecule with functions that extend far beyond hemostasis. PROS1 is a ligand for the TAM family receptor tyrosine kinases TYRO3 and MERTK and, as such, regulates diverse cellular processes including proliferation, migration, phagocytosis, vascular homeostasis, and immune modulation. These activities are mediated through both circulating and locally produced PROS1 and are pathological context-dependent. In the present review, we first summarize our current knowledge on the regulation of PROS1 gene expression and protein structure. We then discuss its established anticoagulant mechanisms alongside emerging activated protein C-independent functions. Finally, we examine key regulatory roles of protein S-TAM signaling in the vessel wall, central nervous system, inflammation, and cancer. Collectively, these findings position PROS1 as a molecular integrator of coagulation, immunity, and tissue homeostasis and underscore its relevance as both a biomarker and a potential therapeutic target in a broad range of pathophysiological contexts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.